TGFB1 and cancer: Since, the activation of TGFβ signaling impairs the antitumor activity of cytotoxic T cells, and the suppression of TGFβ promotes the anticancer immune response against cancer cells [22], is blocking of TGFβ signaling in the peritumoral space likely to effectively disrupt the progression of RCC?